Recruiting
Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.
ClinicalTrials.gov IDNCT04172753
PhaseNA
Enrollment472
SponsorUniversity Hospital Tuebingen
Age18 Years
SexALL
Conditions studied
Rectal Cancer, Head and Neck Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Oligometastasis, Esophageal Cancer
About this study
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.
Interventions
- Radiation: Radiotherapy on the MR-Linac — Radiotherapy is performed on the 1.5 T MR Linac
- Diagnostic Test: Imaging on the MR Linac — Only imaging performed on the MR Linac
Primary outcomes
- Feasibility of online MR guided Radiotherapy (During every single patients treatment (i.e. between one to seven weeks after the first application of radiotherapy))
Eligibility information
Inclusion Criteria:
* existing indication for radiation therapy
* minimum age 18 years, no upper age limit
* capacity for consent
* Informed consent
Exclusion Criteria:
* contraindication for MRI (claustrophobia, metallic implants not applicable for MRI
* pregnancy
Study locations
- University Hospital Tübingen, Department of Radiation Oncology, Tübingen, Baden-Wurttemberg 72076 Germany
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.